RJFSA
BMY.RT

Raymond James Financial Services Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-88,676
Closed -$61K – 3316
2020
Q4 		$61K Sell
88,676
-26,701
-23% -$56.9K ﹤0.01% 2898
2020
Q3 		$260K Buy
115,377
+642
+0.6% +$1.83K ﹤0.01% 2367
2020
Q2 		$411K Sell
114,735
-701
-0.6% -$2.53K ﹤0.01% 2036
2020
Q1 		$439K Buy
115,436
+3,697
+3% +$12.2K ﹤0.01% 1639
2019
Q4 		$336K Buy
+111,739
New +$291K ﹤0.01% 2248

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Raymond James Financial Services Advisors's BMY.RT Position: Q1 2021 in Review

Raymond James Financial Services Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 88,676 shares — an estimated $61K sold.

Raymond James Financial Services Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $439K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Raymond James Financial Services Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 88,676 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $61K.
  • Raymond James Financial Services Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Raymond James Financial Services Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $439K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2021, filed 14 May 2021.